Although AI shows significant promise in diagnosing and managing age-related macular degeneration, its efficacy is reduced by ...
Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...
The multimodal imaging included colour fundus photography, fundus autofluorescence (FAF), spectral domain enhanced depth imaging optical coherence tomography (OCT), en face OCT, OCT-angiography ...
Retinal pigment epithelium changes, the presence of macular drusen and disruption of the foveal ellipsoid zone were compatible with dry age-related macular ... investigation included retinal fundus ...
With more than 200 million people affected worldwide, AMD constitutes the most common ... deep anterior lamellar keratoplasty; DED, dry eye disease; DL, deep learning; DR, diabetic retinopathy; FA, ...
Ophthalmologists must take measures to avoid misdiagnosing age-related macular degeneration and consider mimics of the ...
Wet AMD involves abnormal blood vessel growth, while dry AMD progresses through macular thinning, with both types having distinct symptoms. Early detection is vital due to minimal early-stage ...
The pharmaceutical industry is increasingly focused on developing pathway-based therapies for dry AMD, with promising treatments like ALK-001 and LBS-008 in trials, though a combination approach ...
PST-611 is a first in class non-viral vectorized therapy for the treatment of dry age-related macular degeneration (AMD)/geographic atrophy (GA), expressing human transferrin, a highly potent iron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback